Treating HCV in Prisons
In the Connecticut correctional system, success rates for HCV treatment with pegylated interferon and ribavirin were high, but fewer than 1 in 1000 presumably HCV-infected inmates were actually tested and treated.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)